Prenatal Cannabis Exposure Linked to Higher ADHD and Autism Risk in Children

A meta-analysis of 14 studies involving 203,783 participants found prenatal cannabis exposure associated with increased ADHD symptoms and a 30% higher risk of autism spectrum disorder in offspring.

Tadesse, Abay Woday et al.·Journal of psychiatric research·2024·Strong EvidenceMeta-Analysis
RTHC-05752Meta AnalysisStrong Evidence2024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Meta-Analysis
Evidence
Strong Evidence
Sample
N=203,783

What This Study Found

Prenatal cannabis exposure was associated with increased ADHD symptoms (B=0.39, p=0.001) and a 30% higher risk of ASD (RR=1.30, p<0.05). Stratified analysis showed elevated ADHD symptom scores (B=0.54) and a marginally significant increase in diagnosed ADHD (RR=1.13, CI: 1.01-1.26) among exposed offspring.

Key Numbers

14 studies, 203,783 participants. ADHD symptoms: B=0.39 (CI: 0.20-0.58), I2=66.85%. ASD: RR=1.30 (CI: 1.03-1.64), I2=45.5%. ADHD symptom score in stratified analysis: B=0.54 (CI: 0.26-0.82). Diagnostic ADHD: RR=1.13 (CI: 1.01-1.26).

How They Did This

Systematic review and meta-analysis with preregistered PROSPERO protocol. Searched PubMed/Medline, Scopus, EMBASE, Web of Science, PsycINFO, and Google Scholar. 14 primary studies included (10 on ADHD, 4 on ASD) with 203,783 total participants. Inverse variance weighted random effects model.

Why This Research Matters

ADHD and ASD are among the most common neurodevelopmental disorders, and identifying modifiable risk factors is a public health priority. This meta-analysis provides pooled evidence that prenatal cannabis exposure may be one such factor.

The Bigger Picture

These findings add to the growing picture of prenatal cannabis risks. Combined with evidence on birth defects, birth weight, and attention problems, the body of evidence increasingly suggests that cannabis exposure during fetal development has measurable neurodevelopmental consequences.

What This Study Doesn't Tell Us

Moderate heterogeneity for ADHD outcome (I2=66.85%). Only 4 studies on ASD limits that analysis. Underlying studies vary in how cannabis exposure was measured. Confounders including concurrent substance use and socioeconomic factors are variably controlled.

Questions This Raises

  • ?Is the ADHD association driven by a specific gestational window of exposure?
  • ?Does the 30% ASD risk increase hold up in larger studies?
  • ?Would controlling for all confounders eliminate the associations?

Trust & Context

Key Stat:
30% higher ASD risk with prenatal cannabis exposure
Evidence Grade:
Preregistered meta-analysis with appropriate methods, though limited by moderate heterogeneity and small number of ASD studies.
Study Age:
2024 meta-analysis
Original Title:
Prenatal cannabis use and the risk of attention deficit hyperactivity disorder and autism spectrum disorder in offspring: A systematic review and meta-analysis.
Published In:
Journal of psychiatric research, 171, 142-151 (2024)
Database ID:
RTHC-05752

Evidence Hierarchy

Meta-Analysis / Systematic ReviewCombines many studies into one answer
This study
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal Study

Combines results from multiple studies to find an overall pattern.

What do these levels mean? →

Frequently Asked Questions

Does cannabis use during pregnancy increase ADHD risk?

This meta-analysis of 10 studies found prenatal cannabis exposure associated with significantly higher ADHD symptom scores in children. The risk for diagnosed ADHD was also marginally elevated.

Is prenatal cannabis linked to autism?

Based on 4 studies in this meta-analysis, prenatal cannabis exposure was associated with a 30% higher risk of ASD, though the limited number of studies means this finding needs further confirmation.

Read More on RethinkTHC

Cite This Study

RTHC-05752·https://rethinkthc.com/research/RTHC-05752

APA

Tadesse, Abay Woday; Dachew, Berihun Assefa; Ayano, Getinet; Betts, Kim; Alati, Rosa. (2024). Prenatal cannabis use and the risk of attention deficit hyperactivity disorder and autism spectrum disorder in offspring: A systematic review and meta-analysis.. Journal of psychiatric research, 171, 142-151. https://doi.org/10.1016/j.jpsychires.2024.01.045

MLA

Tadesse, Abay Woday, et al. "Prenatal cannabis use and the risk of attention deficit hyperactivity disorder and autism spectrum disorder in offspring: A systematic review and meta-analysis.." Journal of psychiatric research, 2024. https://doi.org/10.1016/j.jpsychires.2024.01.045

RethinkTHC

RethinkTHC Research Database. "Prenatal cannabis use and the risk of attention deficit hype..." RTHC-05752. Retrieved from https://rethinkthc.com/research/tadesse-2024-prenatal-cannabis-use-and

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.